HYFTMindWalk Holdings Corp.
$1.85
$0.05
(2.78%)
Closed $1.85
$0.00
(0.00%)
After Hours
EarningsJul 14
Mkt Cap$84.08M
Vol260,965.00
Fundamentals
Mkt Cap
$84.08M
Volume
-
52W High
$3.25
52W Low
$0.51
PE Ratio
-9.72
Avg. Volume
459,795.27
EPS (Annual)
-$0.6499
Rev/Employee
$172,512.68
Earnings
Jul 14
MindWalk's Preclinical Dengue Data Support a HYFT Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Campaigns
MindWalk Holdings Corp. (Nasdaq: HYFT) today reported preclinical dengue data that support a computational prediction its HYFT platform generated before any animal was immunized. HYFT computationally identified a candidate pan-serotype structural target on the dengue virus. The subsequent...
Business Wire
MindWalk Holdings Deploys Pandemic Response Platform via HYFT Technology as Ebola and Hantavirus Outbreaks Expose the Limits of Strain-Specific Coverage
MindWalk Holdings Corp. (NASDAQ: HYFT), a bio-native AI therapeutic research and technology company, today announced the launch of its Pandemic Response Platform, a deployment configuration of the Company's proprietary HYFT biological pattern system and LensAI platform purpose-built for outbreak...
Business Wire
The Biology Came First.
MindWalk Holdings Corp. (NASDAQ: HYFT) today released a systematic report identifying over 20 discovery-originated drug candidates with documented origins in antibody discovery work performed at...
Business Wire
MindWalk (NASDAQ:HYFT) Stock Rating Upgraded by JonesTrading
JonesTrading raised MindWalk to a "strong-buy" rating in a research note on Wednesday...
MarketBeat
MindWalk (NASDAQ:HYFT) Now Covered by JonesTrading
JonesTrading assumed coverage on shares of MindWalk in a research report on Thursday. They issued a "buy" rating and a $5.00 price target on the stock...
MarketBeat
MindWalk (NASDAQ:HYFT) Stock Price Up 1.9% - Should You Buy?
MindWalk (NASDAQ:HYFT) Stock Price Up 1.9% - Still a Buy...
MarketBeat
MindWalk (NASDAQ:HYFT) Announces Earnings Results
MindWalk (NASDAQ:HYFT - Get Free Report) released its earnings results on Thursday. The company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of...
MarketBeat
MindWalk Holdings Corp. (HYFT) Reports Q3 Loss, Lags Revenue Estimates
MindWalk Holdings Corp. (HYFT) delivered earnings and revenue surprises of -50.00% and -14.34%, respectively, for the quarter ended January 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results
MindWalk Holdings Corp. (Nasdaq: HYFT), a Bio-Native AI company focused on biologics discovery and AI-driven drug development, today reported financial results for the third quarter of fiscal year...
Business Wire
Stagwell (STGW) Q4 Earnings and Revenues Top Estimates
Stagwell (STGW) delivered earnings and revenue surprises of +5.26% and +2.65%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks
<
1
2
...
>
Advertisement|Remove ads.
Latest HYFT News
ViewMindWalk's Preclinical Dengue Data Support a HYFT Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Campaigns
Business Wire
MindWalk Holdings Deploys Pandemic Response Platform via HYFT Technology as Ebola and Hantavirus Outbreaks Expose the Limits of Strain-Specific Coverage
Business Wire
The Biology Came First.
Business Wire
Advertisement|Remove ads.